Introduction. Recurrent Aphthous Stomatitis (RAS) is a common oral mucosal disorder which is characterized by recurrent ulcerations mainly confined to non-keratinized oral mucosa. Though the exact etiology is imprecise, stress and anxiety were found to be linked with the onset of RAS. The present study was directed to know the prevalence of RAS among female dental students in King Khalid University, to find out the association between RAS and psychological stress and the effectiveness of Hospital Anxiety and Depression scale (HADS) in finding out the psychological profile of RAS patients.Method. 122 female dental students of age group 17 to 25 years were selected for the study. Subjects with relevant medical problems and deleterious habits were excluded. A questionnaire comprising general stress related questions and HAD scale were used to assess stress. Those who were giving history of ulcer were diagnosed as RAS based on the clinical features. The questionnaire results were used for statistical analysis and processed.Result. 14% of the total students were having RAS. 70% could correlate the onset of ulcer with certain specific factors; stress being the major causative agent (91%). In HAD scale, 88% of students were having anxiety and 65% had depression; all patients with depression had anxiety.Conclusion. The prevalence of RAS in female dental students in KKU was around 14%. There is a strong relationship between psychological stress and RAS, as in most of the other studies. HAD scale alone can be used for detecting the psychological factor in RAS.
Tooth root caries account for 10.1% of all dental caries in the USA. This study developed a multifunctional resin coating with calcium (Ca) and phosphate (P) ion release and antibacterial properties to combat root caries. The effects of nano-sized amorphous calcium phosphate (NACP) and dimethylaminohexadecyl methacrylate (DMAHDM) on mechanical, physical, and antibacterial properties against Streptococcus mutans, and cytotoxicity on dental pulp stem cells and gingival fibroblasts were evaluated. A coating resin combining urethane dimethacrylate (UDMA), triethylene glycol divinylbenzyl ether (TEGDVBE), DMAHDM, and NACP was synthesized and compared with Seal&Protect and Vanish XT. Experimental groups (UV + 5% DMAHDM + 10%, 15%, and 20% NACP) showed flexural strength (70.9 ± 8.0 to 81.1 ± 6.0) MPa, significantly higher than Seal&Protect (48.2 ± 7.2) MPa (p < 0.05) and comparable to Vanish XT (70.2 ± 13.6) MPa, (p > 0.05). Elastic modulus (2.2 to 3.3) GPa was lower than Vanish XT (9.4 ± 1.1) GPa (p < 0.05). Experimental groups showed an 8 log CFU reduction, 96% reduction in metabolic activity and 87% in lactic acid production, and increased Ca (1.25 ± 0.03) mmol/L and P (0.8 ± 0.001) mmol/L release over 35 days. Cytotoxicity for experimental groups against dental pulp stem cells and human gingival fibroblast was low and matched those of commercial controls already used in clinic. The resin demonstrated potent antibacterial properties, high ion release, low cytotoxicity, and maintained physical and mechanical integrity, offering potential to prevent root caries formation and progression.
Provisional crowns are often used in dentistry for prolonged periods, but bacterial attachment and dental plaque often lead to gingival inflammation and secondary caries. The aims of this research were to develop a novel resin-based antibacterial provisional crown coating to prevent secondary caries and investigate the physical properties and antibacterial efficacy. The resin-based coating was prepared by addition of triethylene glycoldivinylbenzyl ether and urethane dimethacrylate, with the antibacterial monomer dimethylaminododecyl methacrylate (DMADDM) incorporated at different mass fractions. Surface characteristics including surface roughness and contact angle were assessed. The antibacterial effects were evaluated by 48 h biofilms of Streptococcus mutans (S. mutans) on provisional crowns coated with the resin-based coating. No statistically significant difference was observed in surface roughness across all groups (p > 0.05), showing that adding DMADDM did not have a negative impact on surface roughness. The contact angle results revealed a significant difference in hydrophilicity between different concentrations of DMADDM (p < 0.01), but overall hydrophilicity did not negatively affect the performance of the coating. The incorporation of 5% DMADDM demonstrated a significant antibiofilm effect on S. mutans biofilm CFU with a 4-log reduction compared to controls (p < 0.01). Significant reductions of 4–5 folds were observed in biofilm metabolic activity and lactic acid production (p < 0.01). The findings suggest that the novel coating material could enhance the long-term performance and clinical outcomes of provisional crowns, contributing to better patient oral health.
Metformin is a promising small molecule for dentin regeneration, but an effective local delivery system for pulp applications has been underexplored. This study encapsulated metformin in poly(lactic-co-glycolic acid) (PLGA) microspheres and incorporated them into calcium phosphate–chitosan cement (CPCC) as a direct pulp-capping material (DPC). Metformin-PLGA microspheres were prepared by double emulsion and mixed with CPCC at a concentration of 0% to 20% by weight. Microsphere morphology, encapsulation efficiency, chemical composition, and physico-mechanical properties were characterized, and compatibility with human dental pulp stem cells (hDPSCs) was evaluated by live/dead assay and SEM. The microspheres were spherical (5.43 ± 0.17 µm) with (51 ± 3.69%) encapsulation efficiency, and FTIR confirmed metformin incorporation. The 15% Met-PLGA-CPCC group showed flexural strength (15.22 ± 1.98 MPa), elastic modulus (4.60 ± 0.73 GPa), and work of fracture (104.96 ± 12.48 J/m2) comparable to or higher than CPCC and MTA, while all Met-PLGA-CPCC groups had shorter setting times ranging from 18 min to 27 min than CPCC (39.15 ± 2.10 min) and MTA (123 ± 4.2 min). Metformin release increased proportionally with Met-PLGA content. hDPSCs exhibited good attachment and high viability on all materials over the evaluated period. In conclusion, Met-PLGA-CPCC provides fast-setting and favorable physico-mechanical properties, sustained metformin delivery, and excellent hDPSC compatibility. These properties support its potential as a bioactive direct pulp-capping material and as a versatile platform for regenerative applications.
Secondary caries and biofilm accumulation remain major causes of failure in provisional crowns and restorations, highlighting the need for multifunctional resin coatings with antibacterial and remineralizing capabilities. This study aimed to develop a novel bioactive and antibacterial resin-based surface coating incorporating 10% dimethylaminododecyl methacrylate (DMADDM), 20% nanoparticles of amorphous calcium phosphate (NACP), and/or 20% calcium fluoride nanoparticles (nCaF2) within a urethane dimethacrylate/triethylene glycol divinylbenzyl ether (UDMA/TEG-DVBE) matrix. Coatings were evaluated for degree of conversion (DC), flow, shear bond strength, brushing wear resistance (10,000 cycles), and calcium (Ca), phosphate (PO4), and fluoride (F) ion release up to 70 days. All groups achieved clinically acceptable polymerization, with the lowest DC at 50%. NACP-containing coatings significantly increased shear bond strength to 18.3 ± 2.8 MPa, representing a ~170% increase compared with the experimental control (6.8 ± 2.1 MPa) and exceeding the ISO 10477 minimum threshold of 5 MPa. After brushing simulation, experimental coatings demonstrated low wear depth (0.93–1.19 µm), which was ~40% lower than the commercial control (1.85 ± 0.40 µm). Sustained ion release was achieved for 70 days, with 20% NACP-formula releasing 1.22 mmol/L Ca and 0.90 mmol/L PO4, while the dual NACP–nCaF2 formulation provided simultaneous Ca (0.62 mmol/L) and F (0.33 mmol/L) release. The developed coatings demonstrated promising physicochemical properties, bonding performance, wear resistance, and sustained remineralizing ion release, supporting their potential application as therapeutic surface coatings for provisional restorations.
1 January 2016 in King Khalid University Journal of Health Sciences
Gorlin-Goltz syndrome is an autosomal dominant inherited syndrome. It is also known as hereditary cutaneo-mandibular polyonocosis, multiple nevoid basal cell epithelioma-jaw cysts or bifid rib syndrome. Clinical criteria required for the diagnosis of Gorlin-Goltz syndrome includes a positive family history of the syndrome, presence of basal cell carcinomas, jaw cysts, and palmoplantar pits. The aim is to present the diagnosis, clinical features, and management of Gorlin-Goltz syndrome. Presented here is case series of three males suffering from Gorlin-Goltzsyndrome, their clinical manifestations and management. In conclusion, oral and maxillofacial manifestations of GorlinGotz syndrome play an important role in the diagnosis, initiate early preventive treatment and provide genetic advice, hence a thoroughknowledge of the clinical management is important. Early diagnosis and management of Gorlin-Goltz syndrome are important to avoid complications associated with thesyndrome.